Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatitis B virus presurface protein 1 (preS1) is a domain of the large envelope protein (L-HBsAg) essential for viral infectivity. It mediates attachment to hepatocytes via interaction with NTCP and HSPG. The N-terminal region contains the NTCP-binding site, and myristoylation is critical for receptor binding. PreS1 is a target for antiviral drugs and is also recognized by neutralizing antibodies.
Blocks HBV entry by binding to NTCP
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B surface antigen presurface protein 1 (None).